Innate and adaptive immunity in inflammatory bowel disease

Area of Science:

• Immunology
• Gastroenterology
• Genetics

Background:

• Inflammatory bowel disease (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), lacks a definitive cause.
• Genetic susceptibility combined with an aberrant immune response to gut microbiota is implicated in IBD pathogenesis.
• While adaptive immunity was historically emphasized, innate immune responses are now recognized as crucial for gut inflammation in IBD.

Purpose of the Study:

• To elucidate the roles of both innate and adaptive immune responses in the pathogenesis of IBD.
• To differentiate the specific immune mechanisms contributing to CD versus UC.
• To explore the complex interplay between different immune cells and pathways in driving gut inflammation.

Main Methods:

• Review of current immunological and genetic evidence.
• Analysis of epithelial barrier function in UC.
• Investigation of innate immune responses (antimicrobial peptides, microbial sensing, autophagy) in CD.
• Examination of T helper (Th)1, Th2, Th17, and regulatory T (Treg) cell involvement.

Main Results:

• Altered epithelial barrier function is linked to UC.
• Aberrant innate immune responses, including antimicrobial peptide production and autophagy, are associated with CD.
• Th17 and Treg cells are implicated in IBD, though Th17 cells may also have protective roles.
• Targeting IL-17A showed no improvement in CD, highlighting pathway complexity.

Conclusions:

• Both innate and adaptive immunity are vital in IBD pathogenesis.
• Distinct immune dysregulations characterize CD and UC.
• Further research into the intricate interactions of immune components is necessary to understand gut inflammation and develop effective therapies.